Evaluattion of the correlation between serum ferritin and iron overload of liver, spleen and heart in β -Thalassaemia major patients by mri t2* method
Main Article Content
Abstract
SUMMARY
Objective: MRI T2* is an accurate non-invasive method for assessing organ iron overload. This study evaluated the correlation between serum ferritin and iron overload of liver, spleen and heart in β - thalassaemia major patients by MRI T2* method.
Materials-Methods: A cross-section, descriptive study was designed. We used MRI-T2* to evaluated the correlation between
serum ferritin and iron overload of liver, spleen and heart in 24 thalassaemia major patients admitted in ChoRay hospital from
10/2013 to 1/2014.
Results: Moderate negative correlation between serum ferritin and liver, spleen MRI T2* relaxation time (r = 0,57 and 0,755) and a weak negative correlation between serum ferritin and heart MRI T2* relaxation time (r = 0,303). Liver and heart MRI T2* readings were poorly correlated (r = 0, 28).
Conclusion: MRI T2* is useful to evaluate the iron overload status in β thalassemia patients.
Article Details
Keywords
Serum ferritin, MRI T2*, β -Thalassemia major
References
1. Anderson LJ. Assessment of iron overload with T2* magnetic resonace imaging. Progress in cardiovascular Diseases, 2011, 54:287-294.
2. Anderson LJ et al. Cardiovascular T2* magnetic resonance for early diagnosis of myocardial iron overload. European Heart Journal, 2001, 22:2171- 2179.
3. Andrew T2*: an ROC study. The Internet Journal of Gastroenterology, 2009, 8 (2): 1528-1532.
4. Argyropoulou MI, Astrakas L. MRI evalution of tissue iron burden in patients with β - Thalassaemiamajor. Pediatric Radiology, 2007, 37:183-190.
5. Azarkeivan A et al. Relation between serum ferritin and liver and heart MRI T2* in β thalassaemia major patients. Eastern Mediterranean Health Journal, 2012, 19: 727-380.
6. Casey J. Brewer et al. Spleen R2 and R2* in iron-overload patients with sickle cell disease and thalassemia major. J Magn Reson Imaging, 2009, 29 (2): 357-364.
7. Cohen AR et al. Thalassemia. Hematology (American society of Hematology Education Program). Washington DC, American Society of Hematology, 2004: 14-34.
8. Hamed EA, El Melegy NT. Renal functions in pediatric patients with β - thalassemia major: relation to chelation therapy: original prospective study. Italian Journal of Pediatrics, 2010, 6:39.
9. Jane S Hankins, et al. R2* magnetic resonace imaging of the liver in patients with iron overload. Blood, 2009, 113 : 4853-4857.
10. Jonh-Paul Carpenter, et al. On T2* magnetic resonance and cardia ciron. Circulation, 2011, 1519- 1528.
11. Kirk P et al. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. Journal of Magnetic Resonace Imaging, 2010, 32:315-319.
12. Kirk P et al. Cardiac T2* magnetic resonance for the prediction of cardiac complications in thalassemia major. Circulation, 2009, 120:1961-1968.
13. Leung AW et al. Magnetic resonace imaging assessment of cardiac and liver iron load in transfusion depent patients. Pediatric blood and cancer, 2009, 53: 1054-1059.
14. Ping Hou et al. A practical approach for a wide range of liver iron quantitation using a magnetic resonace imaging technique. Radiology research and practice, 2012, 2012: 2073-2082.
15. St pierre TG et al. Noninvasive measurement and imaging of lievr iron concentrations using proton magnetic resonace. Blood, 2005, 105:855-861.
16. Tanner MA et al. Thalassemia International Ffederation Heart T2* Investigators. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica, 2006, 91:1388-1391.
17. Wood JC. Diagnosis and magnagement of transfusion iron overload: the role of imaging. PMC, 2010, 82: 1132-1135.
18. Wood JC. Magnetic resonace imaging measurement of iron overload. Current Opinion Hematology, 2007, 14:183-190.
19. Worwood M et al. Bingding of serum ferritin to concavalin A: patients with homozygous β thalassaemia and transfusional iron overload. British Joural of Haematology, 1980, 46:409-416.
20. Yesilipek MA. Stem cell transplantation in hemoglobinopathies. Hemoglobin, 2007, 31: 251-256.